King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar noparking (< 20) Submitted: 5/14/2008 10:40:59 AM : Outperform Start Price: $9.70 KG Score: +50.16

The King of... something.

Report this Post Reply

Featured Broker Partners


Advertisement